Correlation Between Pliant Therapeutics and BioAffinity Technologies
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and BioAffinity Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and BioAffinity Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and bioAffinity Technologies Warrant, you can compare the effects of market volatilities on Pliant Therapeutics and BioAffinity Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of BioAffinity Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and BioAffinity Technologies.
Diversification Opportunities for Pliant Therapeutics and BioAffinity Technologies
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pliant and BioAffinity is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and bioAffinity Technologies Warra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAffinity Technologies and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with BioAffinity Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAffinity Technologies has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and BioAffinity Technologies go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and BioAffinity Technologies
Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the BioAffinity Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Pliant Therapeutics is 17.04 times less risky than BioAffinity Technologies. The stock trades about -0.03 of its potential returns per unit of risk. The bioAffinity Technologies Warrant is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 43.00 in bioAffinity Technologies Warrant on September 1, 2024 and sell it today you would earn a total of 29.00 from holding bioAffinity Technologies Warrant or generate 67.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 74.51% |
| Values | Daily Returns |
Pliant Therapeutics vs. bioAffinity Technologies Warra
Performance |
| Timeline |
| Pliant Therapeutics |
| BioAffinity Technologies |
Pliant Therapeutics and BioAffinity Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and BioAffinity Technologies
The main advantage of trading using opposite Pliant Therapeutics and BioAffinity Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, BioAffinity Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies will offset losses from the drop in BioAffinity Technologies' long position.| Pliant Therapeutics vs. Tff Pharmaceuticals | Pliant Therapeutics vs. Eliem Therapeutics | Pliant Therapeutics vs. Inhibrx | Pliant Therapeutics vs. Enliven Therapeutics |
| BioAffinity Technologies vs. bioAffinity Technologies, | BioAffinity Technologies vs. AAP Inc | BioAffinity Technologies vs. Discount Print USA | BioAffinity Technologies vs. China Dongsheng International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |